Lumateperone

Lumateperone for Late-Life Depression

A Study of Lumateperone Versus Placebo in Participants With Major Depressive Disorder

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

Study of Lumateperone in the Treatment of Patients With Bipolar Mania

Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania

This Study Aims to Compare the Efficacy and Safety of Lumateperone and Cariprazine in Patients With Bipolar I Depression Using Montgomery-Åsberg Depression Rating Scale (MADRS) and Clinical Global Impression Bipolar Severity Scale (CGI-BP-S) and Recording Treatment Emergent Adverse Effects.

Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia

An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder

Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine

Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally